15 mg Mirtazapine Orally Disintegrating Tablets, Fasting
Clinical trial NCT00835575 · COMPLETED
Trial details
- NCT number
- NCT00835575
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2003-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.